This is a research study to determine how best to build a 6-month family-centered weight loss intervention or program for adults who self-identify as African American or Black. We know that standard weight loss programs do not work as well for Black adults, especially women, and addressing the cultural importance of family can improve weight loss success. This study will look at how best to combine different family program components to reach the best weight loss outcomes.

We want to learn how personality traits relate to how adolescents and young adults who are shy or whose emotions and moods change quickly make decisions. We hope this research will help us better understand decision-making and mental health during the transition from adolescence to adulthood.

Do you have incurable, metastatic, or recurrent head and neck squamous cell carcinoma? If so, you may be able to participate in a study to evaluate the addition of the anti-cancer drug, Cetuximab, to standard of care treatment.

The purpose of this study to see if the drug ruxolitinib with the drugs tacrolimus and methotrexate given before and following a peripheral blood stem cell transplant will prevent graft-versus-host disease (GVHD), a serious complication of a stem cell transplant, better than the drugs post-transplant cyclophosphamide, tacrolimus, and mycophenolate mofetil.

Do you have sickle cell trait or wonder if you might? Join our study to learn more about how having sickle cell trait could impact your health. The study uses simple lab tests, and participants receive compensation.

To determine how Athletic Trainers' perceive the effectiveness of concussion risk reduction strategies and how their experiences vary in dealing with concussion risk reduction strategies.

If you have a solid tumor that has not responded to other treatments and have no remaining therapy options, you may be eligible for the trial. Participants will receive the study drug at no cost.

If you have non-small cell lung cancer and are not currently receiving treatment, you may be eligible to participate in a study testing a combination of drugs to treat your cancer-study drugs will be provided.

If you have non-squamous non-small cell lung cancer and are not currently in treatment, you may qualify for a clinical trial testing a new drug to treat tumors-study drug provided.

Are you newly diagnosed with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) and looking for treatment options? Our study is evaluating new therapies specifically designed for patients with these conditions. If you have not previously tried an anti-cancer therapy for AML/MDS, this study might be for you!